Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBCN.L Regulatory News (BCN)

  • There is currently no data for BCN

Form 8 (OPD) Bacanora Lithium plc - Amendment

7 Sep 2021 14:22

RNS Number : 0135L
Bacanora Lithium PLC
07 September 2021
 

The following amendment has been made to the Form 8 (OPD) announcement released on 19/05/2021 under RNS 1440Z.

 

An amendment has been made to section 3(a) to display the correct interest held by Eileen Carr. All other details remain unchanged. The full amended text is shown below.

 

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Bacanora Lithium plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bacanora Lithium plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

6 September 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 10p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

0

NIL

0

(2) Cash-settled derivatives:

 

NIL

0

NIL

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

0

NIL

0

 

TOTAL:

NIL

0

NIL

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests of directors of Bacanora Lithium plc in Bacanora Lithium plc's ordinary shares of 10 pence each

 

Name

Number of ordinary shares of 10 pence each

Percentage of total issued share capital (%) (excluding any shares held under option)

Mark Hohnen

3,012,547

0.91%

Peter Secker

336,250

0.10%

Jamie Strauss

102,857

0.03%

Eileen Carr

88,888

0.02%

 

(b) Details of awards granted to the directors of Bacanora Lithium plc over Bacanora Lithium plc's ordinary shares of 10 pence each

 

Name

Number of ordinary shares of 10 pence each

Percentage of total issued share capital (%) (excluding any shares held under option)

Grant date

Exercise price (p)

Expiry date

Peter Secker

205,800

0.06%

28 Oct'19

33.25p

27 Oct'22

Peter Secker

215,488

0.06%

2 Oct'20

24.40p

1 Oct'23

Mark Hohnen

151,439

0.05%

28 Oct'19

33.25p

27 Oct'22

Mark Hohnen

179,501

0.05%

2 Oct'20

24.40p

1 Oct'23

 

(c) Details of RSUs granted to the directors of Bacanora Lithium plc over Bacanora Lithium plc's ordinary shares of 10 pence each

 

Name

Number of ordinary shares of 10 pence each

Percentage of total issued share capital (%) (excluding any shares held under option)

Grant date

Vesting date

Peter Secker

278,546

0.08%

28 Oct'19

27 Oct'22

Peter Secker

117,420

0.04%

2 Oct'20

1 Oct'23

Mark Hohnen

204,970

0.06%

28 Oct'19

27 Oct'22

Mark Hohnen

97,811

0.03%

2 Oct'20

1 Oct'23

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

7 September 2021

Contact name:

Peter Secker

Telephone number:

info@bacanoralithium.com

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEXDLFBFKLBBBQ
Date   Source Headline
7th Sep 20182:03 pmRNSGrant of Options and Restricted Share Units
31st Aug 20188:46 amRNSExercise of Options
7th Aug 20187:00 amRNSQuarterly Sonora Lithium Project Update
19th Jul 20187:00 amRNSUpdate on Financing Package for Sonora Project
16th Jul 20181:00 pmRNSProposed Placing to raise US$100 million
16th Jul 20181:00 pmRNSInvestments by SGRF of Oman & Hanwa
5th Jul 20187:00 amRNSUS$150M Debt Funding Secured for Lithium Project
2nd Jul 20187:00 amRNSUpdate on Financing Strategy for Sonora Project
4th Jun 20188:00 amRNSPositive Progress at Sonora Lithium Project
24th May 20187:00 amRNSThird Quarter Financial Statements
11th May 201811:30 amRNSIssue of Equity on Exercise of Options
20th Apr 201812:35 pmRNSDirectorate Change and Grant of Options
6th Apr 20187:00 amRNSSonora Project Update
4th Apr 20187:00 amRNSCorporate Update & Zinnwald Lithium Project Review
29th Mar 20182:40 pmRNSHolding(s) in Company
27th Mar 20184:40 pmRNSSecond Price Monitoring Extn
27th Mar 20184:35 pmRNSPrice Monitoring Extension
26th Mar 20188:10 amRNSFirst Day of Dealings
22nd Mar 20185:45 pmRNSSchedule One Update - Bacanora Lithium Plc
21st Mar 20185:45 pmRNSSchedule One Update - Bacanora Lithium Plc
20th Mar 20187:00 amRNSResult of Annual and Special Meeting
19th Mar 20185:41 pmRNSUpdated Re-domicile Timetable
2nd Mar 20187:00 amRNSInterim Results
28th Feb 20187:00 amRNSUpdate re Investor Financing
20th Feb 201811:20 amRNSSchedule One - Bacanora Lithium plc
19th Feb 20187:00 amRNSPosting of Circular and Notice of GM
9th Feb 20187:00 amRNSProposed Re-domicile
6th Feb 20187:00 amRNSAppointment of Non-Exec Director and CFO
1st Feb 20187:00 amRNSUpdate re Strategic Cornerstone Investor Financing
25th Jan 20187:00 amRNSFiling of NI-43-101 Feasibility Study For Sonora
10th Jan 201810:02 amRNSDirector/PDMR Shareholding
22nd Dec 20177:00 amRNSFinal Results - Replacement
21st Dec 20177:00 amRNSIssue of Equity
15th Dec 20177:00 amRNSStrategic Cornerstone Investor & Offtake Agreement
13th Dec 20177:00 amRNSSonora Feasibility Study: USD1.25BN NPV & 26% IRR
4th Dec 20177:00 amRNSDirectorate Change
28th Nov 20177:00 amRNS1st Quarter Financial Statements
24th Nov 201711:30 amRNSTransaction Notification
20th Nov 20177:00 amRNSCorporate Update
8th Nov 20177:00 amRNSMining Licence Issued for Lithium Project, Germany
2nd Nov 20177:00 amRNSSurface Rights Secured for Sonora Lithium Project
25th Oct 20177:00 amRNSFinal Results
20th Oct 20177:00 amRNSEnvironmental Approval for Sonora Lithium Project
29th Sep 20179:58 amRNSExercise of Warrants and Options / Issue of Equity
25th Sep 201710:45 amRNSTransaction Notification
20th Sep 20172:15 pmRNSRestricted Share Plan and Director Dealings
8th Sep 20175:30 pmRNSTransaction Notification
8th Sep 20174:53 pmRNSHolding(s) in Company
8th Sep 20172:50 pmRNSHolding(s) in Company
7th Sep 20175:35 pmRNSUpdate on Shareholder Ownership & Director Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.